Shiyu Capital Closes Second China Healthcare Fund with $473 Million

00:56 EDT 12 Apr 2019 | ChinaBio Today

Shiyu Capital of Shenzhen closed its second China life science PE fund with $473 million in capital. The fund, called Danqing Fund II, will invest in pharma/biotech, healthcare, IVD and medical services companies. The Danqing funds aim to participate in the "historic opportunity" of transforming China's pharmaceutical industry. The company's first fund, launched in 2016, raised $164 million. Both funds are RMB denominated. Shiyu Capital, also known as Shenzhen Shiyu Investment Management, was established in 2014. More details....

Share this with colleagues:

Original Article: Shiyu Capital Closes Second China Healthcare Fund with $473 Million


More From BioPortfolio on "Shiyu Capital Closes Second China Healthcare Fund with $473 Million"

Quick Search


Relevant Topics

Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...